In bleomycin-induced lung injury, a prolonged exposure to S1P1 functional antagonists including fingolimod not only worsened the vascular barrier function but also increased the fibrotic response (Shea et al., 2010), suggesting that S1P1 acts anti-fibrotic in pulmonary fibrosis. Here, S1PR1 is linked to pulmonary fibrosis.